Derivative exercise or conversion — not an open-market buy.
Traded Mar 16, 2026 · Filed Mar 19, 2026
Baker Hughes's Chief Growth & Experience Ofcr sold $3.3M of Baker Hughes shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$3,302,298
Shares × reported transaction price
49 days after results of Jan 26, 2026, 38 days before results of Apr 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $55.19 on Mar 16, 2026, 58% above its 52-week low and 15% below its high, after a 2% drop over the previous 30 trading days
52-week range $35.00 (Apr 8, 2025) to $65.26 (Feb 27, 2026), 67% of the way up, from 251 adjusted closes. 30 trading days earlier: $56.04 on Jan 30, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.7% | -2.2% | +5.0% |
| 30 days | -2.5% | +7.4% | -9.9% |
| 90 days | -1.1% | +12.3% | -13.3% |
| 180 days | -6.6% | +14.8% | -21.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$16M of Baker Hughes
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.